AI PRICE FORECAST
MET Stock Forecast & AI Price Prediction
MetLife · Financial Services · Insurance - Life
MET live signal snapshot
MET last traded at $102.94, up 0.49% on the session, trading 3.5% below its 52-week high of $106.72 and 52.9% above its 52-week low of $67.33. Stock Pulse 247's AI model currently rates MET a BUY, at 72% model confidence. Short-term moving averages are mixed right now, without a clean bullish or bearish stack forming yet. The model's one-month path points toward roughly $106.73 (3.7% from here).
On the 14-day relative strength index, MET reads 62.6, showing buyers in control without the stretch of an overbought reading. Its MACD line is above its signal line with a positive histogram (0.06) — upward momentum is accelerating. Its 50-day average ($98.56) is holding 13.7% above the 200-day ($86.67), the pattern chartists call a golden cross.
The average 12-month target from 16 Wall Street analysts is $110.63 (range $84.00–$131.00) — 7.5% upside from where MET trades now. The current recommendation trend leans bullish: 13 Buy/Strong Buy ratings vs 1 Sell/Strong Sell (and 4 Hold).
Live figures from real market data feeds, current as of the last site build. Open the interactive MET dashboard for numbers updated throughout today's session.
About MetLife
MetLife, Inc. (MET) is an insurance - life company in the financial services sector, headquartered in New York, NY, United States. MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It has a market value of about $64.7 billion and roughly 46,000 full-time employees. Its beta of 0.77 means it has historically moved roughly in line with the market.
MET performance vs. the market
MET is up 30.4% so far in 2026, ahead of the S&P 500 (+11.4%) and ahead of the financial services sector fund XLF (+7.0%). On a one-year view it is up 33.4%, 21.9 points better than the S&P 500. The last month (+2.3%) continues the three-month advance (+5.6%).
| Period | MET | Sector (XLF) | S&P 500 |
|---|---|---|---|
| 1 month | +2.3% | +7.0% | −2.3% |
| 3 months | +5.6% | +0.6% | −2.3% |
| Year to date | +30.4% | +7.0% | +11.4% |
| 1 year | +33.4% | +10.7% | +11.5% |
MetLife financials at a glance
In the quarter ended Sep 30, 2026, MetLife reported revenue of $19.9 billion and net income of $2.4 billion (a 11.8% net margin). Revenue was up 18.2% from the same quarter a year earlier. The stock trades at a price-to-earnings ratio of 13.5 on trailing earnings of $7.65 per share. Trailing free cash flow was −$3.5 billion, and total debt equals 224% of shareholders' equity.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Sep 30, 2026 | $19.9B | $2.4B |
| Jun 30, 2026 | $19.1B | $705M |
| Mar 31, 2026 | $19.7B | $1.1B |
| Dec 31, 2025 | $24.2B | $778M |
MET vs. its peers
Against 5 of its largest financial services peers, MET's +30.4% year-to-date return beats 5 of them. None of them has done better this year.
| Company | Price | YTD | P/E | AI verdict |
|---|---|---|---|---|
| MetLife (MET) | $102.94 | +30.4% | 13.5 | BUY |
| Aflac (AFL) | $127.11 | +15.3% | 18.6 | BUY |
| Prudential Financial (PRU) | $123.04 | +9.0% | 11.2 | BUY |
| JPMorgan Chase (JPM) | $343.39 | +6.6% | 14.4 | BUY |
| Visa (V) | $425.55 | +21.3% | 34.5 | BUY |
| Mastercard (MA) | $660.73 | +15.7% | 34.6 | BUY |
MET stock: common questions
What is the MET stock price target?
16 Wall Street analysts put the average 12-month target at $110.63, in a range of $84.00–$131.00, versus a recent price of $102.94. Stock Pulse 247's model projects about $106.73 over the next month.
Is MET a buy right now?
Our AI model currently rates MET a BUY at 72% confidence. Among analysts, 13 rate it Buy or Strong Buy, 4 Hold and 1 Sell. Neither is personal advice — weigh them with your own research and risk tolerance.
How has MET stock performed this year?
MET is up 30.4% so far in 2026, ahead of the S&P 500 (+11.4%) and ahead of the financial services sector fund XLF (+7.0%). On a one-year view it is up 33.4%, 21.9 points better than the S&P 500. The last month (+2.3%) continues the three-month advance (+5.6%).
What is MET's 52-week high and low?
MET has traded between $67.33 and $106.72 over the past 52 weeks; at $102.94 it is 3.5% below its 52-week high of $106.72 and 52.9% above its 52-week low of $67.33.
What sector is MET in, and who are its peers?
MET is in the financial services sector (insurance - life). Its largest peers on Stock Pulse 247 include Aflac (AFL), Prudential Financial (PRU), JPMorgan Chase (JPM), Visa (V).
How accurate is the MET forecast?
It's a model estimate from price history, technical indicators and analyst targets, not a guarantee — no model predicts short-term moves reliably. Use it as one input alongside your own research.
How this works: the forecast combines MET's price history, momentum indicators (RSI, MACD, moving averages), volatility and analyst targets into one estimate. It's a model, not a guarantee.